Sulzer buys private Canadian tissue heart valve business
This article was originally published in Clinica
Executive Summary
Sulzer Medica has bought the privately held Canadian company, Mitroflow Enterprise, for around $27 million, to strengthen its position in the growing tissue valve sector. Mitroflow manufactures a bovine pericardial tissue heart valve which has been CE-marked for sale in Europe but is not yet approved in the US.